SCHEMBL3205143

SCHEMBL3205143

COc1ccc(N(Cc2cncs2)c2ccc(C(=O)OC(C)(C)C)cc2)cc1OC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 2/20 0.38
POLB P06746 2/20 0.38
HPGD P15428 1/20 0.38
PARP15 Q460N3 1/20 0.35
PARP10 Q53GL7 1/20 0.35
GAA P10253 3/20 0.34
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
PDE4D Q08499 1/20 0.34
MAPK1 P28482 1/20 0.34
LMNA P02545 2/20 0.34
HDAC6 Q9UBN7 1/20 0.34
MAPT P10636 2/20 0.34
MTNR1A P48039 1/20 0.34
MTNR1B P49286 1/20 0.34
TSHR P16473 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3204089 0.93 TSHR (0.40) KDM4EHPGDMAPK1HDAC6MAPT
SCHEMBL3205815 0.93 HRH4 (0.38) ALDH1A1KDM4EHPGDPARP15PARP10
SCHEMBL3199311 0.93 RXRA (0.37) ALDH1A1KDM4EPOLBHPGDPARP15
SCHEMBL3129127 0.92 POLB (0.36) ALDH1A1KDM4EPOLBHPGDGAA
SCHEMBL3215114 0.92 HDAC6 (0.36) ALDH1A1KDM4EPOLBHPGDPARP15
SCHEMBL2905045 0.92 MKNK1 (0.38) ALDH1A1KDM4EPOLBHPGDPARP15
SCHEMBL2908021 0.91 HTT (0.36) ALDH1A1KDM4EPARP15PARP10KMT2A
SCHEMBL2908195 0.91 HDAC6 (0.34) ALDH1A1HPGDPARP15PARP10KMT2A
SCHEMBL2901840 0.91 ALDH1A1 (0.35) ALDH1A1KDM4EPOLBHPGDGAA
SCHEMBL3201671 0.90 HDAC6 (0.32) ALDH1A1KDM4EPOLBHPGDPARP15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B ALDH1A1 190/4885KDM4E 162/4885POLB 1798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.